Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$338K Sell
4,772
-2,594
-35% -$194K 0.02% 352
2025
Q4
$581K Sell
7,366
-12,340
-63% -$977K 0.07% 279
2025
Q3
$1.62M Sell
19,706
-9,484
-32% -$746K 0.29% 85
2025
Q2
$2.35M Buy
+29,190
New +$2.25M 0.26% 97
2023
Q1
Sell
-29,459
Closed -$2.13M 629
2022
Q4
$2.13M Buy
+29,459
New +$2.11M 0.34% 80
2022
Q2
Sell
-22,740
Closed -$1.63M 586
2022
Q1
$1.63M Buy
+22,740
New +$1.54M 0.29% 101
2021
Q4
Sell
-12,465
Closed -$769K 398
2021
Q3
$769K Buy
+12,465
New +$750K 0.19% 144
2020
Q3
Sell
-6,303
Closed -$230K 857
2020
Q2
$230K Buy
+6,303
New +$219K 0.08% 309

Other funds holding MET

FORA Capital's MET Position: Q1 2026 in Review

FORA Capital reduced its MetLife (MET) stake by 35% in Q1 2026, selling an estimated $194K and leaving 4,772 shares worth $338K. The position accounts for 0.02% of the portfolio, ranked #352.

FORA Capital first reported a position in MET in Q2 2020 and has held it in 8 quarters since. The position peaked at $2.35M in Q2 2025. 1,371 funds tracked by Wall St. Rank hold MET as of Q1 2026.

  • FORA Capital held 4,772 shares of MetLife worth $338K as of Q1 2026.
  • FORA Capital sold 2,594 MetLife shares in Q1 2026, an estimated $194K.
  • MetLife made up 0.02% of FORA Capital's portfolio in Q1 2026, its #352 holding.
  • FORA Capital first reported a position in MetLife in Q2 2020 and has held it in 8 quarters since.
  • FORA Capital's MetLife position peaked at $2.35M in Q2 2025.
  • 1,371 funds tracked by Wall St. Rank held MetLife as of Q1 2026.

Based on FORA Capital's 13F filing for Q1 2026, filed 15 May 2026.